157 related articles for article (PubMed ID: 17450522)
21. Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.
Kaneko M; Kaneko S; Suzuki K
Cancer Sci; 2009 Nov; 100(11):2193-201. PubMed ID: 19673886
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
23. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
[TBL] [Abstract][Full Text] [Related]
24. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
[TBL] [Abstract][Full Text] [Related]
25. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
27. Combinational Treatment Effect of Tetrahydrocurcumin and Celecoxib on Cervical Cancer Cell-Induced Tumor Growth and Tumor Angiogenesis in Nude Mice.
Yoysungnoen B; Bhattarakosol O; Changtam C; Patumraj S
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S23-31. PubMed ID: 29916670
[TBL] [Abstract][Full Text] [Related]
28. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
29. Modulation of 5-fluorouracil in mice using uridine diphosphoglucose.
Codacci-Pisanelli G; Kralovanszky J; van der Wilt CL; Noordhuis P; Colofiore JR; Martin DS; Franchi F; Peters GJ
Clin Cancer Res; 1997 Feb; 3(2):309-15. PubMed ID: 9815688
[TBL] [Abstract][Full Text] [Related]
30. [Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].
Gao J; Li JS; Xu GL; Jia WD; Ma JL; Yu JH; Ge YS
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):900-4. PubMed ID: 21205474
[TBL] [Abstract][Full Text] [Related]
31. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.
Klenke FM; Gebhard MM; Ewerbeck V; Abdollahi A; Huber PE; Sckell A
BMC Cancer; 2006 Jan; 6():9. PubMed ID: 16409625
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells.
Park JS; Jun HJ; Cho MJ; Cho KH; Lee JS; Zo JI; Pyo H
Clin Cancer Res; 2006 Aug; 12(16):4989-99. PubMed ID: 16914589
[TBL] [Abstract][Full Text] [Related]
33. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Yee KK; Soo KC; Olivo M
Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
[TBL] [Abstract][Full Text] [Related]
34. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.
Zhang B; Ma X; Li Z; Gao X; Wang F; Liu L; Shen G; Sang Y; Li M; Li Y; Zhao J; Wei Y
J Cancer Res Clin Oncol; 2013 May; 139(5):797-807. PubMed ID: 23385883
[TBL] [Abstract][Full Text] [Related]
36. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
[TBL] [Abstract][Full Text] [Related]
37. CS-706, a novel cyclooxygenase-2 selective inhibitor, prolonged the survival of tumor-bearing mice when treated alone or in combination with anti-tumor chemotherapeutic agents.
Senzaki M; Ishida S; Yada A; Hanai M; Fujiwara K; Inoue S; Kimura T; Kurakata S
Int J Cancer; 2008 Mar; 122(6):1384-90. PubMed ID: 18027868
[TBL] [Abstract][Full Text] [Related]
38. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
[TBL] [Abstract][Full Text] [Related]
39. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]